Smart Destinations takes $10M for online tourist passes
Smart Destinations, a Boston company that sells discounted admission passes to tourist attractions across the country, just landed $7 million in third-round funding and $3 million in debt financing to diversify its offerings. Right now, it hawks unlimited passes usable in 15 cities. For example, its “Go San Francisco Card” grants access to Alcatraz, the AT&T Park Tour, the Exploratorium and 50 other landmarks and events at a 35 percent markdown. The site offers cards… Continue Reading
The FeedRoom raises $12M more for online video
The FeedRoom, which provides web video technology for media companies, corporations and government agencies, has raised an additional $12 million of financing. The round was led by NewSpring Capital, with participation from existing investors BEV Capital and Velocity Equity Partners.
It’s a pretty venerable company, having been around for 10 years, but chief executive Mark Portu shook things up a bit last year when he took over and started building a new leadership team. The New… Continue Reading
Life-science briefing: Monday, March 10, 2008
TODAY’S HEADLINES:
BrainCells raises $30M for neuroregeneration drugs (release)
EKR Therapeutics takes in $50M plus $95M in debt for pain, heart drugs (release)
Wright Medical acquires Berkeley’s Inbone Tech for $24M (release)
Argolyn Bioscience names Nixon Ellis as CEO (release)
BrainCells raises $30M for neuroregeneration drugs – San Diego’s BrainCells, a startup focused on drugs intended to stimulate the growth of new neurons, raised $30 million in a second funding round. Investors included MedImmune Ventures, Bay City Capital, Oxford Bioscience Partners,… Continue Reading
Life sciences briefing: Thursday, Aug. 30, 2007
Featured companies: Entelos, Firstsource Solutions, Helixis, Iconix Biosciences, MedAssist Holding, Songbird Hearing
Entelos pays up to $39M for Iconix Biosciences — In a rare all-Bay Area biotech transaction, Foster City, Calif.’s Entelos agreed to acquire Iconix Biosciences for up to $39.1 million in stock. The deal consists of an up-front payment of $14.1 million in Entelos shares and a potential “earn out payment” of $25 million if certain financial milestones are met. The acquisition is scheduled to… Continue Reading
Life sciences briefing: Wednesday, Aug. 15, 2007
(UPDATED at 5:55pm PT: See below.)
Featured companies: Sierra Surgical Technologies, HerbalScience Nutraceuticals, Topigen Pharmaceuticals, EKR Therapeutics, Molecular Partners, Celsense, Glucose Sensing Technologies, Falcon Genomics, Waters, Calorimetry Sciences, Parion Sciences, Gilead Sciences, Isto Technologies, Fluidnet, NABsys
Sierra Surgical raises $7.1M — Palo Alto, Calif.-based Sierra Surgical Technologies, a developer of female sterilization technology, raised $7.1 million in a first funding round, PE Hub reports, citing a regulatory filing. Alta Partners and De Novo Ventures provided the funding.
Singapore’s HerbalScience raises… Continue Reading